Page last updated: 2024-12-08
rubrofusarin gentiobioside
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
rubrofusarin gentiobioside: isolated from seeds of Cassia tora; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Cassia | genus | A plant genus of the family FABACEAE. Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus (SENNA PLANT) and some to CHAMAECRISTA.[MeSH] | Fabaceae | The large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 503733 |
CHEMBL ID | 3634699 |
MeSH ID | M0306123 |
Synonyms (14)
Synonym |
---|
5-hydroxy-8-methoxy-2-methyl-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-benzo[g]chromen-4-one |
5-hydroxy-8-methoxy-2-methyl-4-oxo-4h-benzo[g]chromen-6-yl 6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranoside |
rubrofusarin gentiobioside |
chembl3634699 , |
bdbm50133113 |
5-hydroxy-8-methoxy-2-methyl-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxybenzo[g]chromen-4-one |
24577-90-0 |
rubrofusarin-6-o-beta-gentiobioside |
rubrofusarin-6-o-beta-d-gentiobioside |
AKOS037515346 |
HY-N4177 |
CS-0032324 |
MS-30580 |
DTXSID301310928 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (2)
Inhibition Measurements
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 (µMol) | 37.5000 | 0.0004 | 0.9086 | 10.0000 | AID1256631 |
Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 (µMol) | 37.5000 | 0.0000 | 0.5450 | 9.1000 | AID1256631 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Biological Processes (8)
Process | via Protein(s) | Taxonomy |
---|---|---|
response to toxic substance | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
positive regulation of gene expression | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
dephosphorylation | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
cholesterol homeostasis | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
stilbene catabolic process | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
phospholipid dephosphorylation | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
regulation of cholesterol metabolic process | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
epoxide metabolic process | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Molecular Functions (8)
Process | via Protein(s) | Taxonomy |
---|---|---|
magnesium ion binding | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
epoxide hydrolase activity | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
toxic substance binding | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
phosphatase activity | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
lipid phosphatase activity | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
protein homodimerization activity | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
lysophosphatidic acid phosphatase activity | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Ceullar Components (4)
Process | via Protein(s) | Taxonomy |
---|---|---|
peroxisome | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
peroxisomal matrix | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
cytosol | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
extracellular exosome | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
peroxisome | Bifunctional epoxide hydrolase 2 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1256630 | Inhibition of sEH (unknown origin) assessed as 6-methoxy-2-naphthaldehyde formation at 50 uM by fluorometry assay using 40 uM cyano-(6-methoxy-naphthalen-2-yl)-methyl ester as substrate | 2015 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22 | Constituents of the seeds of Cassia tora with inhibitory activity on soluble expoxide hydrolease. |
AID1256631 | Inhibition of sEH (unknown origin) assessed as 6-methoxy-2-naphthaldehyde formation by fluorometry assay using 40 uM cyano-(6-methoxy-naphthalen-2-yl)-methyl ester as substrate | 2015 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22 | Constituents of the seeds of Cassia tora with inhibitory activity on soluble expoxide hydrolease. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.87) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |